Skip to content

Race and ethnicity moderate the associations between lifetime psilocybin use and past year hypertension

Grant Jones, Jocelyn A. Ricard, Matthew K. Nock

Frontiers in Psychiatry June 24, 2024 DOI: 10.3389/fpsyt.2024.1169686 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Observational cross-sectional analysis Longitudinal Peer reviewed
Population Respondents to the National Survey on Drug Use and Health (2005–2014)
Intervention Psilocybin
Topics Psilocybin
Keywords Nsduh Race Drug epidemiology Psilocybin research Racial health disparities Hypertension studies Psychedelic medicine
Citations 5
Key findings Psilocybin use was associated with reduced odds of past-year hypertension only among Non-Hispanic White individuals, not among other racial or ethnic groups.

Abstract

Background: Hypertension is a major source of morbidity and mortality worldwide, particularly for racial and ethnic minorities who face higher rates of hypertension and worse health-related outcomes. Recent research has reported on protective associations between classic psychedelics and hypertension; however, there is a need to explore how race and ethnicity may moderate such associations.

Methods: We used data from the National Survey on Drug Use and Health (2005–2014) to assess whether race and ethnicity moderate the associations between classic psychedelic use – specifically psilocybin – and past year hypertension.

Results: Hispanic identity moderated the associations between psilocybin use and past year hypertension. Furthermore, individuals who used psilocybin and identified as Non-Hispanic White had reduced odds of hypertension (aOR: 0.83); however, these associations were not observed for any other racial or ethnic groups in our study for individuals who used psilocybin.

Conclusion: Overall, our results demonstrate that the associations between psychedelics and hypertension may vary by race and ethnicity. Longitudinal studies and clinical trials can further advance this research and determine whether such differences exist in causal contexts. Project registration https://osf.io/xsz2p/?view_only=0bf7b56749034c18abb2a3f8d3d4bc0b .

Comparable studies

Other cross-sectional and survey studies on psilocybin, most cited first.

Study Year Design Participants
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences Individuals who had consumed psilocybin mushrooms and experienced a psychologically... 2016 Cross-sectional survey n = 1,993
The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms Internet survey respondents reporting challenging experiences with psilocybin 2016 Questionnaire development and validation
Psychedelics and Mental Health: A Population Study Adult population in the United States 2013 Cross-sectional survey n = 130,152
Cessation and reduction in alcohol consumption and misuse after psychedelic use Individuals with prior alcohol use disorder who reported cessation or reduction in... 2019 Cross-sectional survey n = 343
Patterns of simultaneous polysubstance use in drug using university students Drug-using university students 2006 Cross-sectional survey n = 149

Citations in the library

Explore topics